Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GMCL1 (Germ cell-less 1, spermatogenesis associated) encodes a nuclear envelope protein conserved across species and is likely involved in spermatogenesis in humans, either directly or by influencing genes linked to sperm cell development. The protein contains a BTB/POZ domain, a motif commonly found in proteins involved in protein-protein interactions and the regulation of cellular processes. Functional studies in non-human models (e.g., Drosophila) suggest GMCL1 homologs play critical roles in transcriptional suppression, centrosome dynamics, and cell fate determination during early germ cell formation. In mammals, there is preliminary evidence that GMCL1 may influence the p53 pathway by modulating MDM2 degradation, but its direct biological functions in humans remain incompletely defined. GMCL1 is not considered a classical therapeutic target (such as receptor, enzyme, transporter, etc.) and has no established clinical modulators or diagnostic biomarkers.
Not applicable; no drugs known to target GMCL1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Germ cell-less 1, spermatogenesis associated (GMCL1).